Projects per year
Personal profile
Research interests
Research Interests
My research interests are in medication utilisation and medication safety in vulnerable populations, especially those not usually included in phase III clinical trials. I also undertake research into epidemiology of autoimmune diseases and occurrence of serious outcomes. I am a statistician and develop statistical models for these research projects. Most of the research that I do uses anonymised primary care records from the Clinical Practice Research Datalink (CPRD).
Medication use and safety in pregnancy
This research group has considerable experience in carrying out medication utilisation and safety studies in pregnant women using CPRD data. We have our own algorithm to identify pregnancies and outcomes that has been developed and refined over many years. We have used this to evaluate the prescribing and safety of medications for epilepsy, diabetes, high cholesterol, depression and asthma during pregnancy.
Medication use and safety in older people
Older people, especially those with many comorbidities, do not participate in clinical trials therefore being able to use the CPRD to investigate disease occurrence, prescribing and medication safety gives considerable insight into the health of these populations especially very frail or the oldest patients. Areas of interest include dementia, rheumatoid diseases, cerebrovascular disease and diabetes.
Epidemiology of autoimmune diseases
Current work includes evaluating incidence, prevalence and outcomes associated with systemic sclerosis to try to better understand prognosis of this disease and its effects. As a rare disease, work is being undertaken to evaluate different statistical models to use in evaluating time to event models that incorporate both incident and prevalent cases of disease and outcomes.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Pharmacy research priorities in the South-West: engaging and involving patients, the public and healthcare professionals
Jones, M. (PI), Jones, S. (CoI), McGrogan, A. (CoI), Rennie, T. (CoI), Slatter, M. (CoI) & Mitchell, A. (CoI)
1/02/24 → …
Project: Research-related funding
-
Dementia and serious outcomes: top up funding for HES and SES data
McGrogan, A. (PI)
1/11/23 → 31/03/25
Project: Other
-
Using big data to investigate foetal and child outcomes following exposure to antiepileptics in pregnancy
McGrogan, A. (PI), Charlton, R. (Researcher) & Ehrhardt, B. (Researcher)
1/09/23 → 28/02/26
Project: UK charity
-
Validity of the Myositis Muscle Dysfunction Scale (MMDS) in adult patients with Polymyositis and Dermatomyositis
McGrogan, A. (CoI), Lange, E. (PI) & McHugh, N. (CoI)
Project: UK charity
-
Dementia and serious health outcomes: a cohort and case control study investigating psychological distress as a risk factor
McGrogan, A. (PI), Welsh, T. J. (CoI) & Jarvis, A. (Researcher)
Project: Other
-
Safety and effectiveness of anticoagulation therapy in older people with atrial fibrillation during exposed and unexposed treatment periods
Mitchell, A., Watson, M., Welsh, T. & McGrogan, A., 14 Jan 2025, (Acceptance date) In: Heart.Research output: Contribution to journal › Article › peer-review
-
Changes in the incidence and prevalence of systemic lupus erythematosus between 1990 and 2020: an observational study using the Clinical Practice Research Datalink (CPRD)
Ellis, J., McHugh, N., Pauling, J. D., Bruce, I. N., Charlton, R., McGrogan, A. & Skeoch, S., 27 Jul 2024, In: Lupus Science & Medicine. 11, 2, e001213.Research output: Contribution to journal › Article › peer-review
Open Access -
Identifying and Predicting Risk for Hospital Admission among Patients with Parkinsonism
Tenison, E., McGrogan, A., Ben-Shlomo, Y. & Henderson, E., 6 Nov 2024, (E-pub ahead of print) In: Movement Disorders Clinical Practice.Research output: Contribution to journal › Article › peer-review
Open Access -
Pay to puff green: can NHS incentives change the prescribing practices?
Howell, A., McGrogan, A. & Jones, M., 3 Nov 2024, In: Thorax. 79, A135.Research output: Contribution to journal › Meeting abstract
Open Access -
Pay to puff green: can NHS incentives change prescribing practices?
Howell, A., McGrogan, A. & Jones, M., 19 Sept 2024.Research output: Contribution to conference › Poster
Datasets
-
Dataset for "User-testing guidelines to improve the safety of intravenous medicines administration: a randomised in-situ simulation study"
Jones, M. (Creator), McGrogan, A. (Creator), Raynor, D. K. (Creator), Watson, M. (Creator) & Franklin, B. D. (Creator), University of Bath, 3 Jun 2020
DOI: 10.15125/BATH-00751
Dataset
-
Dataset for "Temporal and geographical variation in low carbon inhaler dispensing in England, 2016 to 2021: an ecological study"
Tian, J. (Creator), McGrogan, A. (Creator) & Jones, M. (Creator), University of Bath, 16 Nov 2022
DOI: 10.15125/BATH-01142
Dataset
-
Primary Care Data for Health Research
McGrogan, A. (Speaker)
3 Oct 2024Activity: Public, Community and School Engagement › Public talk, lecture, debate, seminar, workshop
-
Member of Digital and Data Science Ethics Committee (Event)
McGrogan, A. (No value)
1 Apr 2023 → 1 Sept 2024Activity: Other contribution to the discipline › Role on a committee, board or panel
-
Epilepsy Research Institute UK (External organisation)
McGrogan, A. (No value)
1 Nov 2023Activity: Other contribution to the discipline › Role on a committee, board or panel